Head-to-Head

Ironwood Pharmaceuticals, Inc. - Class A vs. Johnson & Johnson

IRWD

Ironwood Pharmaceuticals, Inc. - Class A

$4.25 +2.91%

VS JNJ

Johnson & Johnson

$265.85 -0.82%

Johnson & Johnson (JNJ) comes out ahead, leading on 5 of 9 compared factors.

Size & Scale

IRWDJNJ
Market Cap $682.44 million $645.95 billion
Revenue (TTM) $389.32 million $97.93 billion
Net Income (TTM) $129.87 million $21.04 billion

JNJ leads on 3 of 3 size & scale factors.

Valuation

IRWDJNJ
P/E Ratio 5.52 30.84
Price / Book -4.22 7.60
Price / Sales 1.75 6.60

IRWD leads on 3 of 3 valuation factors.

Profitability

IRWDJNJ
Net Margin 33.36% 21.48%
Return on Equity -80.24% 24.76%

IRWD and JNJ split the profitability factors evenly.

Dividend

IRWDJNJ
Dividend Yield — 2.02%
Payout Ratio — 62.18

IRWD and JNJ split the dividend factors evenly.

Risk & Sentiment

IRWDJNJ
Short Interest 11.02% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: IRWD overview, IRWD financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.